Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment

E-ISSN： 1873-4286|20|17|2899-2911

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.17, 2014-05, pp. : 2899-2911

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

By Yuen John SP Macaulay Valentine M

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 589-603

Informa Healthcare

Access to resources Recommend Favorite

Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies

By Yap Timothy A Olmos David Molife Lulama Rhoda de Bono Johann S

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1293-1304

Informa Healthcare

Access to resources Recommend Favorite

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 748-760

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy

Current Drug Targets, Vol. 11, Iss. 9, 2010-09 ,pp. : 1121-1132

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Insulin and Insulin-Like Growth Factors on Tumor Vascularization: New Insights of Insulin-Like Growth Factor Family in Cancer

Current Medicinal Chemistry, Vol. 16, Iss. 30, 2009-10 ,pp. : 3931-3942

Bentham Science Publishers

Access to resources Recommend Favorite